Mitchell Jones

Mitchell Jones

President chez PALISADE BIO, INC.

Fortune : 28 118 $ au 31/05/2026

48 ans
Health Technology
Consumer Services
Health Services

Profil

Dr. Mitchell L.
Jones is a President & Chief Medical Officer at Palisade Bio, Inc. Dr. Jones was previously employed as a Vice President-Corporate Development & Strategy by Chemomab Therapeutics Ltd., a Vice President-Clinical Discovery & Development by Finch Therapeutics Group, Inc., a VP- Innovation & Clinical Development by Biora Therapeutics, Inc., a Head-Research & Development by Interface Therapeutics, Inc., and a Director, VP-Product Discovery & Design by Micropharma Ltd. He received his undergraduate degree from McGill University, a graduate degree from McGill University and a doctorate degree from McGill University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
20/03/2026 13 263 ( 0,01 % ) 28 118 $ 31/05/2026

Postes actifs de Mitchell Jones

SociétésPosteDébut
PALISADE BIO, INC. President -

Anciens postes connus de Mitchell Jones

SociétésPosteFin
CHEMOMAB THERAPEUTICS LTD. Corporate Officer/Principal 01/11/2023
FINCH THERAPEUTICS GROUP, INC. Corporate Officer/Principal 01/11/2022
BIORA THERAPEUTICS, INC. Corporate Officer/Principal 01/07/2020
Interface Therapeutics, Inc.
Fondateur -
Fondateur -
Voir l'expérience en détail de Mitchell Jones

Formation de Mitchell Jones

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés liées

Entreprise privées7

Health Technology

Consumer Services

Health Technology

Health Services

Health Technology

Health Technology

Interface Therapeutics, Inc.

  1. Bourse
  2. Insiders
  3. Mitchell Jones
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇